BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21382095)

  • 21. Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.
    Miyanaga T; Hirato J; Nakazato Y
    Neuropathology; 2008 Apr; 28(2):116-26. PubMed ID: 18021194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.
    Nobusawa S; Watanabe T; Kleihues P; Ohgaki H
    Clin Cancer Res; 2009 Oct; 15(19):6002-7. PubMed ID: 19755387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.
    Lasota J; Miettinen M
    Histopathology; 2008 Sep; 53(3):245-66. PubMed ID: 18312355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A YAC contig spanning a cluster of human type III receptor protein tyrosine kinase genes (PDGFRA-KIT-KDR) in chromosome segment 4q12.
    Spritz RA; Strunk KM; Lee ST; Lu-Kuo JM; Ward DC; Le Paslier D; Altherr MR; Dorman TE; Moir DT
    Genomics; 1994 Jul; 22(2):431-6. PubMed ID: 7528718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The activated targets of mTOR signaling pathway are characteristic for PDGFRA mutant and wild-type rather than KIT mutant GISTs.
    Sápi Z; Füle T; Hajdu M; Matolcsy A; Moskovszky L; Márk A; Sebestyén A; Bodoky G
    Diagn Mol Pathol; 2011 Mar; 20(1):22-33. PubMed ID: 21326036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
    Andersson J; Bümming P; Meis-Kindblom JM; Sihto H; Nupponen N; Joensuu H; Odén A; Gustavsson B; Kindblom LG; Nilsson B
    Gastroenterology; 2006 May; 130(6):1573-81. PubMed ID: 16697720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-derived growth factor receptor family mutations in gastrointestinal stromal tumours.
    Sihto H; Franssila K; Tanner M; Vasama-Nolvi C; Sarlomo-Rikala M; Nupponen NN; Joensuu H; Isola J
    Scand J Gastroenterol; 2006 Jul; 41(7):805-11. PubMed ID: 16785193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Array comparative genomic hybridization reveals frequent alterations of G1/S checkpoint genes in undifferentiated pleomorphic sarcoma of bone.
    Niini T; Lahti L; Michelacci F; Ninomiya S; Hattinger CM; Guled M; Böhling T; Picci P; Serra M; Knuutila S
    Genes Chromosomes Cancer; 2011 May; 50(5):291-306. PubMed ID: 21254299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-resolution melting amplicon analysis as a method to detect c-kit and platelet-derived growth factor receptor alpha activating mutations in gastrointestinal stromal tumors.
    Holden JA; Willmore-Payne C; Coppola D; Garrett CR; Layfield LJ
    Am J Clin Pathol; 2007 Aug; 128(2):230-8. PubMed ID: 17638656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic analyses for predictors of radiation response in glioblastoma.
    Shih HA; Betensky RA; Dorfman MV; Louis DN; Loeffler JS; Batchelor TT
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):704-10. PubMed ID: 15978739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative ultrastructural analysis and KIT/PDGFRA genotype in 125 gastrointestinal stromal tumors.
    Agaram NP; Baren A; Arkun K; Dematteo RP; Besmer P; Antonescu CR
    Ultrastruct Pathol; 2006; 30(6):443-52. PubMed ID: 17182437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.
    Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
    Int J Oncol; 2006 Jun; 28(6):1361-7. PubMed ID: 16685437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.
    Frederick L; Wang XY; Eley G; James CD
    Cancer Res; 2000 Mar; 60(5):1383-7. PubMed ID: 10728703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas.
    Tamborini E; Miselli F; Negri T; Lagonigro MS; Staurengo S; Dagrada GP; Stacchiotti S; Pastore E; Gronchi A; Perrone F; Carbone A; Pierotti MA; Casali PG; Pilotti S
    Clin Cancer Res; 2006 Dec; 12(23):6920-8. PubMed ID: 17145809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathology of gastrointestinal stromal tumors.
    Hirota S; Isozaki K
    Pathol Int; 2006 Jan; 56(1):1-9. PubMed ID: 16398673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series.
    Gomes AL; Gouveia A; Capelinha AF; de la Cruz D; Silva P; Reis RM; Pimenta A; Lopes JM
    J Clin Pathol; 2008 Feb; 61(2):203-8. PubMed ID: 17827398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA.
    Disel U; Madison R; Abhishek K; Chung JH; Trabucco SE; Matos AO; Frampton GM; Albacker LA; Reddy V; Karadurmus N; Benson A; Webster J; Paydas S; Cabanillas R; Nangia C; Ozturk MA; Millis SZ; Pal SK; Wilky B; Sokol ES; Gay LM; Soman S; Ganesan S; Janeway K; Stephens PJ; Zhu VW; Ou SI; Lovly CM; Gounder M; Schrock AB; Ross JS; Miller VA; Klempner SJ; Ali SM
    Oncologist; 2020 Jan; 25(1):e39-e47. PubMed ID: 31604903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic relevance of KIT and PDGFRA mutations in gastrointestinal stromal tumors.
    Braggio E; Braggio Dde A; Small IA; Lopes LF; Valadão M; Gouveia ME; Moreira Ados S; Linhares E; Romano S; Bacchi CE; Renault IZ; Guimarães DP; Ferreira CG
    Anticancer Res; 2010 Jun; 30(6):2407-14. PubMed ID: 20651400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased gene copy number of KIT and VEGFR2 at 4q12 in primary breast cancer is related to an aggressive phenotype and impaired prognosis.
    Johansson I; Aaltonen KE; Ebbesson A; Grabau D; Wigerup C; Hedenfalk I; Rydén L
    Genes Chromosomes Cancer; 2012 Apr; 51(4):375-83. PubMed ID: 22170730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectrum and prognostication of KIT and PDGFRA mutation in gastrointestinal stromal tumors.
    Tzen CY; Wang MN; Mau BL
    Eur J Surg Oncol; 2008 May; 34(5):563-8. PubMed ID: 17532173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.